cbdMD (YCBD) Net Income towards Common Stockholders Growth (3y) (2019 - 2025)
cbdMD (YCBD) Net Income towards Common Stockholders Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 33.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 4.50% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 26.82% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 66.11% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -17.90% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -30.70% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 253.53% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -109.16% |
| 10 | cbdMD | 3,905.91 | -3.38 Mn | 3.00 Mn | 59.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.69% |
| Sep 30, 2025 | 64.83% |
| Jun 30, 2025 | 66.48% |
| Mar 31, 2025 | 36.03% |
| Dec 31, 2024 | 63.44% |
| Sep 30, 2024 | 35.77% |
| Jun 30, 2024 | -36.68% |
| Mar 31, 2024 | 32.55% |
| Dec 31, 2023 | 40.53% |
| Sep 30, 2023 | -38.45% |
| Jun 30, 2023 | 32.61% |
| Mar 31, 2023 | -29.23% |
| Dec 31, 2022 | -33.58% |
| Sep 30, 2022 | -50.36% |
| Jun 30, 2022 | -5.62% |
| Mar 31, 2022 | 43.75% |
| Dec 31, 2021 | -112.20% |
| Sep 30, 2021 | -69.86% |
| Jun 30, 2021 | 67.99% |
| Mar 31, 2021 | -124.45% |